Overview
Pretransfusion compatibility testing is the sequence of laboratory steps that ensures a unit of donor blood is safe to transfuse into a specific recipient without causing an adverse reaction. It is the final safeguard between the blood bank and the patient.
Far more than just a crossmatch, compatibility testing encompasses accurate patient identification, ABO and Rh grouping, antibody screening, appropriate donor selection, and the saline and antiglobulin crossmatch techniques. A single lapse anywhere in this chain can result in a fatal hemolytic transfusion reaction, which is why every step is governed by strict protocol.
Learning Objectives
After this lesson you will be able to…- List the sequential steps involved in pretransfusion compatibility testing
- Explain the purpose and methods of antibody screening
- Apply the rules for ABO and Rh-compatible blood selection
- Differentiate major and minor crossmatching and their clinical purpose
- Perform the saline and antiglobulin (indirect Coombs) crossmatch techniques
Clinical Story
Why This MattersA 45-year-old man requires an urgent blood transfusion after a road traffic accident with significant blood loss. The blood bank technologist must rapidly but accurately complete the compatibility testing chain — from correct sample identification through to crossmatching — because any shortcut risks a life-threatening hemolytic transfusion reaction in an already critically injured patient.
Core Concepts
Compatibility testing comprises: review of the patient's transfusion history; receiving a correctly identified and labeled sample with an accompanying request form; ABO and Rh grouping of the recipient; antibody screening of the recipient's serum; selection of an appropriate donor unit; ABO and Rh testing of the donor; antibody screening of donor serum; and finally crossmatching. Every sample must be checked to confirm the details on the form and the vial tally exactly.
The recipient's serum is screened for clinically significant irregular (unexpected) antibodies using saline technique at room temperature, enzyme technique, and the indirect antiglobulin technique at 37°C. Group O panel cells carrying antigens of the Rh, Kidd, Kell, Duffy, MNS, Lutheran, and Lewis systems are used, tested alongside the patient's own cells (autocontrol) and cord cells. If an antibody's specificity cannot be identified and blood is urgently needed, the patient's serum is crossmatched against multiple units of the same ABO/Rh type.
Blood of the same ABO group as the patient is always preferred. If unavailable, compatible alternatives may be used (e.g., group O for group A or B patients). AB patients unable to receive AB blood should preferentially receive group A rather than group B, since anti-B in group A individuals is weaker than anti-A in group B donors. Bombay blood group patients must receive only Oh blood. For Rh selection: Rh-negative patients must receive Rh-negative blood; Du donor blood is considered Rh positive; Du recipients are treated as Rh negative.
The major crossmatch tests the recipient's serum against donor red cells and is the critical test to detect any antibody in the recipient that would react with donor cells. The minor crossmatch tests donor serum against recipient red cells and may be omitted if the donor's serum has already been screened and found negative for irregular antibodies. Saline technique detects IgM antibodies reacting at room temperature; the antiglobulin (indirect Coombs) technique is the most sensitive and widely used method, detecting clinically significant IgG antibodies.
Laboratory Principle
Compatibility testing works on the principle that if the recipient's serum contains an antibody directed against an antigen present on the donor's red cells, in-vitro mixing of that serum with the donor cells will produce visible agglutination or hemolysis. The saline technique detects room-temperature-reactive IgM antibodies directly, while the indirect antiglobulin technique uses anti-human globulin reagent to bridge and visibly agglutinate cells sensitized with IgG antibodies that would not otherwise cause visible agglutination.
Equipment Required
Reagents & Materials
| Reagent / Material | Concentration / Grade | Purpose | Storage |
|---|---|---|---|
| Normal Saline | 0.9% NaCl | Washing cells and preparing suspensions | Room temperature |
| Polyspecific AHG Serum | Anti-IgG + Anti-C3d | Indirect antiglobulin crossmatch | 2–8°C |
| IgG-Coated Control Cells | Commercial Coombs control cells | Validates negative AHG results | 2–8°C |
| Group O Screening Panel Cells | Commercial 2–3 cell panel | Antibody screening of recipient serum | 2–8°C, use before expiry |
Step-by-Step Procedure
Verify that the labeled sample and accompanying request form details (name, age, sex, hospital number) match exactly before testing begins.
Carry out forward and reverse ABO grouping and Rh(D) typing on the recipient sample by tube technique.
Test the patient's serum against screening panel cells, autocontrol, and cord cells using saline, enzyme, and indirect antiglobulin techniques.
Choose an ABO/Rh compatible donor unit (or alternative if same group unavailable) and confirm the donor's own ABO/Rh group.
Mix recipient serum with donor red cells; carry out saline technique first, then the antiglobulin technique, and grade any agglutination or hemolysis.
Flow Diagram
Quality Control
Every negative antiglobulin crossmatch must be confirmed valid by adding IgG-coated control cells at the final step — agglutination must appear, or the entire test is invalid and must be repeated. Autocontrols are run alongside every antibody screen to rule out autoantibody interference.
Blood banks should participate in national proficiency testing schemes for pretransfusion testing, submitting coded unknown samples for ABO/Rh grouping, antibody screening, and crossmatch interpretation to verify ongoing competency.
Reference Values
Normal Ranges⚠️ Reference ranges may vary between laboratories. Always apply your laboratory's established reference intervals.
Clinical Interpretation
| Finding | Possible Significance | Action / Follow-up |
|---|---|---|
| Negative saline and AHG crossmatch | No detectable antibody incompatibility | Unit may be labeled compatible and issued |
| Agglutination/hemolysis on saline crossmatch | Room-temperature IgM antibody incompatibility, likely ABO | Do not issue; investigate ABO/Rh discrepancy immediately |
| Agglutination only after AHG step | Clinically significant IgG alloantibody present | Select antigen-negative unit; consult blood bank physician |
Common Errors & How to Avoid Them
Cause: Incorrect patient identification at collection or mismatched labels between sample and form is the leading cause of ABO-incompatible transfusion.
Prevention: Enforce strict two-identifier patient verification at both collection and issue; never accept an unlabeled or ambiguously labeled sample.
Cause: Relying on saline crossmatch alone will miss clinically significant IgG antibodies that do not agglutinate at room temperature.
Prevention: Always complete the full antiglobulin (indirect Coombs) crossmatch, especially in previously transfused or multiparous patients.
Cause: Failure to add IgG-coated check cells after a negative AHG result can mask a technical failure (e.g., inadequate washing) that produced a false negative.
Prevention: Always add Coombs check cells to every negative AHG tube and confirm agglutination before reporting compatibility.
Laboratory Tips from the Bench
When time is critical, an immediate-spin saline crossmatch can be used to rule out major ABO incompatibility, but it must always be followed by the full antiglobulin crossmatch as soon as possible.
Suspending donor red cells in low ionic strength saline (LISS) shortens incubation time and increases antibody detection sensitivity — useful when results are needed quickly without compromising safety.
Remember 'Major matters most': the major crossmatch (recipient serum vs donor cells) is the test that truly protects the patient from a hemolytic reaction.
Important Notes
If forward and reverse ABO grouping results do not tally, or if the crossmatch shows any unexplained reaction, the unit must not be released for transfusion until the Blood Bank in-charge resolves the discrepancy.
When AB blood is unavailable for an AB patient, group A blood is preferred over group B because anti-B in group A donors/recipients is characteristically weaker than anti-A in group B individuals.
Interactive Quiz
Test Your KnowledgeFlashcards
Tap to flipClick or tap any card to reveal the answer. Use arrow keys to navigate in single-card mode.
Clinical Case Study
Apply Your KnowledgeBrought to the emergency department with hypotension and significant external blood loss following a road traffic accident. Urgent transfusion is requested by the trauma team.
With no AB units available, and a negative antibody screen, group A blood is the safest alternative for this AB-positive patient, given the weaker anti-B typically present in group A individuals compared to anti-A in group B individuals.
- →In an emergency with an unavailable exact ABO match, established compatibility rules must guide the alternative selection.
- →A negative antibody screen still requires a full crossmatch before issue — screening and crossmatching are complementary, not interchangeable.
- →Speed in an emergency must never bypass the antiglobulin phase of compatibility testing.
Frequently Asked Questions
No. Crossmatching is only one component of the broader compatibility testing process, which also includes patient identification, ABO/Rh grouping, and antibody screening.
The minor crossmatch can be omitted if the donor's serum has already been screened with a panel of cells and shown to be free of irregular antibodies, as is standard practice in most modern blood banks.
Antibody screening uses a standardized panel of cells to detect and help identify unexpected antibodies efficiently, while crossmatching confirms compatibility with the specific donor unit intended for transfusion.
Quick Revision
10-Minute ReviewKey Takeaways
- Pretransfusion compatibility testing is a multi-step safeguard, not a single test.
- Accurate sample identification and labeling prevent the majority of hemolytic transfusion reactions.
- Antibody screening detects clinically significant irregular antibodies before crossmatching begins.
- ABO/Rh-based donor selection rules ensure the safest available alternative when an exact match is not possible.
- The major crossmatch (recipient serum vs donor cells) is the definitive safety check before transfusion.
- The saline and antiglobulin techniques together detect both IgM and clinically significant IgG antibodies.
Competency Checklist
Track Your MasteryReferences
- National Institute of Open Schooling. Hematology and Blood Bank Technique, Lesson 13: Pretransfusion or Compatibility Testing.
- AABB Technical Manual. 20th ed. American Association of Blood Banks.
- Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. 11th ed.